Newly on Gate2Biotech
Veterinary Market – How Innovative?
29.11.2012 | Newly on Gate2Biotech
European veterinary market of new medicinal products noted a dynamic growth over the past 20 years. EU regulations - numerous at that period of time - were smoothly implemented. But what is more significant – veterinary market efficiently resisted the economic slowdown. It is important to mark that such a good condition of the branch is a result...
Getting together at PHARM Connect 2013!
26.11.2012 | Newly on Gate2Biotech
Biotech and Pharma professionals getting together to overcome industry-specific challenges and develop genuine partnerships at PHARM Connect. In the aftermath of the global recession, the pharmaceutical and biotechnology industry has been facing new challenges.
Direvo introduces BluCon™ for the conversion of non-food biomass to biofuel and chemical building blocks
15.11.2012 | Newly on Gate2Biotech
Cologne, Germany, November 12, 2012. Direvo Industrial Biotechnology GmbH is commercializing its BluConTM platform for complete, one-step conversion of non-food feedstocks to carbohydrates used in the production of fuels and chemicals. In the recent years Direvo has undertaken a huge research program identifying a portfolio of proprietary...
Nimbus discovery and Proteros enter into privileged X-RAY crystallography partnership agreement
13.11.2012 | Newly on Gate2Biotech
Martinsried, Germany, November 12, 2012. Proteros biostructures GmbH ("Proteros") today announced that it has executed a Privileged Partnership Agreement with Nimbus Discovery LLC (Nimbus), Cambridge, Massachusetts, USA.
The Top CEE biotech licensing opportunities
29.10.2012 | Newly on Gate2Biotech
Pharmaceutical companies are looking for sources of new products and technologies in biotechnology industry to extend the existing pipeline. The major objectives of pharmaceutical and biotechnology businesses are to be the first on the market with new therapeutic entities, achieve maximum market penetration, be assured of freedom to operate, and...
BioForum opens for the veterinary market!
17.10.2012 | Newly on Gate2Biotech
The innovative bib-business is a main – apart from the IT – driving force of the modern economy. Therefore, every year since 2000 we organize BioForum – the event that meets the needs of the emerging Central European biotech companies and creates the optimal conditions for their development.
New innovative enzyme technologies improving economics for the ethanol and livestock feeding industries
15.10.2012 | Newly on Gate2Biotech
Cologne, Germany, October 8, 2012: Direvo Industrial Biotechnology GmbH is introducing its BluZy™-product development platform, delivering innovative biology-based solutions to improve economics of renewable fuels and livestock feeding markets. Direvo´s most advanced product, BluZy™-D, substantially improves the nutritional value of DDGS and...
Hungarian Biotechnology Association - the main partner of Bioforum 2013
8.10.2012 | Newly on Gate2Biotech
Quite recently, Central European region has regained freedom and undergone deep structural and social changes. Our common objective is to converge with the Western world’s development in terms of technology, bioeconomy and the standard of living.
UCB and Proteros expand successful protein x-ray crystallography collaboration
18.9.2012 | Newly on Gate2Biotech
Collaboration aims to accelerate drug discovery for new therapies in central nervous system (CNS) disorders and immunology diseases.
Sophion announces the Qube - the next generation platform for ion channel screening
6.9.2012 | Newly on Gate2Biotech
Ballerup, Denmark (September 4, 2012). Sophion Bioscience announces the upcoming release of the latest state-of-the-art instrument for automated patch clamp, the Qube.
